Edgewise Therapeutics, Inc. (EWTX) — SC 13D/A Filings

SC 13D/A Filings (4)

• OrbiMed Amends Stake in Edgewise Therapeutics — Nov 12, 2024 Risk: medium
  OrbiMed Advisors LLC and its affiliates have filed Amendment No. 3 to their Schedule 13D, reporting a change in beneficial ownership of Edgewise Therapeutics, I
• Novo Holdings Amends Edgewise Therapeutics Stake — Sep 23, 2024 Risk: medium
  Novo Holdings A/S, through its filing on September 23, 2024, has amended its Schedule 13D regarding Edgewise Therapeutics, Inc. This amendment, designated as Am
• Novo Holdings A/S Amends Edgewise Therapeutics Stake — Jan 25, 2024
  Novo Holdings A/S, a significant shareholder in Edgewise Therapeutics, Inc., filed an Amendment No. 4 to its Schedule 13D on January 25, 2024, indicating a chan
• OrbiMed Amends Edgewise Therapeutics Stake on Jan 23 — Jan 25, 2024
  OrbiMed Advisors LLC and its affiliates, including OrbiMed Capital GP VI LLC, OrbiMed Genesis GP LLC, and OrbiMed Capital LLC, filed an Amendment No. 2 to their

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX